锰补充对肥胖哮喘小鼠肺部炎症反应的防治作用

黄莹, 张志彭, 高亮, 李红, 孟佳, 闫冬莹

营养学报 ›› 2025, Vol. 47 ›› Issue (4) : 352-357.

PDF(2286 KB)
PDF(2286 KB)
营养学报 ›› 2025, Vol. 47 ›› Issue (4) : 352-357.
论著

锰补充对肥胖哮喘小鼠肺部炎症反应的防治作用

  • 黄莹, 张志彭, 高亮, 李红, 孟佳, 闫冬莹
作者信息 +

EFFECTS OF MANGANESE SUPPLEMENTATION ON THE INFLAMMATORY RESPONSE IN THE LUNGS IN OBESE ASTHMATIC MICE

  • HUANG Ying, ZHANG Zhi-peng, GAO Liang, LI Hong, MENG Jia, YAN Dong-ying
Author information +
文章历史 +

摘要

目的 探讨锰补充对卵清蛋白(ovalbumin,OVA)诱导的肥胖哮喘小鼠肺部炎症的影响,为临床治疗提供新思路。方法 60只雄性昆明小鼠随机分为5组:对照组(CON)、肥胖组(HF)、哮喘组(OVA)、肥胖哮喘组(HF+OVA)、肥胖哮喘锰干预组(Mn,下称Mn干预组),每组12只。HF组、HF+OVA组、Mn干预组小鼠给予高脂饲料喂养12 w,CON组及OVA组小鼠给予对照饲料喂养12 w。OVA组、HF+OVA组、Mn干预组小鼠在实验的第9、10、11 w的第1日给予0.05 mg/ml OVA致敏液200 μl腹腔注射致敏,第12 w连续3日,每日鼻滴注入0.05 mg/ml的OVA生理盐水溶液50 μl进行激发。Mn干预组在高脂饮食期间每两日一次鼻内给予1 mg/kg MnCl2。最后一次鼻滴暴露后,观察小鼠哮喘行为学改变,检测小鼠气道高反应性。造模期间每2w测量体重,12 w后测量体脂,取材,石蜡切片观察肺组织病理改变,分类计数小鼠支气管肺泡灌洗液中白细胞数量及中性粒细胞比率,检测血清及肺组织锰含量,分析支气管肺泡灌洗液中白细胞介素-6(interleukin-6,IL-6)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)水平。结果 与CON组比较,HF组小鼠体重增重12.4%,HF+OVA组小鼠增重23.2%,体脂比分别增加46.1%、67.7%,肥胖模型构建成功。OVA组及HF+OVA组小鼠出现挠鼻、点头呼吸等症状,气道反应性升高,表明哮喘模型建立。小鼠肺组织有明显病理改变,炎症细胞数量增多,IL-6、TNF-α水平升高,且HF+OVA小鼠的症状更明显 (P<0.05)。与HF+OVA组小鼠相比,Mn干预组小鼠体重降低17.9%,体脂比降低27.4%,哮喘症状减轻,气道反应性降低,肺组织病理损伤减轻,炎症细胞数量减少,IL-6、TNF-α水平下降 (P<0.05)。结论 Mn补充对肥胖哮喘小鼠肺部炎症反应有防治作用,其机制可能与抑制炎症反应有关。

Abstract

Objective To explore the effects of manganese supplementation on lung inflammation in obese asthmatic mice exposed to ovalbumin (OVA) and to provide new insights for clinical treatment. Methods Sixty male Kunming mice were randomly divided into five groups: control group (CON), obesity group (HF), asthma group (OVA), obese asthma group (HF+OVA), and obese asthmatic manganese intervention group (Mn, hereinafter referred to as the Mn intervention group), with 12 mice in each group. Groups HF, HF+OVA, and Mn were fed a high-fat diet for 12 weeks, and the other two groups were fed a control diet. Mice in the OVA, HF+OVA, and Mn intervention groups were sensitized by intraperitoneal injection of 200 μl of 0.05 mg/ml OVA sensitization solution on the first day of the 9th, 10th, and 11th weeks. On the 12th week, mice were treated by nasal drip 50 μl of 0.05 mg/ml OVA saline solution for 3 consecutive days to induce asthma. During the feeding period of high-fat diet, the Mn intervention group received 1 mg/kg MnCl2 intranasally every two days to induce asthma. After the last nasal drip exposure, asthmatic behavioral changes were observed and airway hyperresponsiveness was measured. Body weight was measured every fortnight during the modeling period, body composition was measured after 12 weeks. Hematoxylin-eosin staining was performed to observe the pathological changes in lung tissues. White blood cells in mouse bronchoalveolar lavage fluid (BALF) were counted and classified. The Mn contents in the serum and lung tissues were detected, and the levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in BALF were analyzed. Results Compared with the CON group, the mice in the HF group gained 12.4% in body weight, while the HF+OVA group gained 23.2%. The body fat ratios increased by 46.1% and 67.7% in the HF and HF+OVA groups, indicating the obesity model was successfully constructed. The mice in the OVA and HF+OVA groups showed symptoms such as nose scratching and nodding breathing, with increased airway hyperresponsiveness, indicating that the asthma model was established. Significant pathological changes were observed in the lung tissue of asthma mice, with an increased number of inflammatory cells and elevated levels of IL-6 and TNF-α. These symptoms were more pronounced in HF+OVA mice (P0.05). Compared with the HF+OVA group, mice in the Mn intervention group showed a 17.9% reduction in body weight and a 27.4% reduction in body fat ratio. Meanwhile, asthma symptoms were mitigated, airway hyperresponsiveness decreased, and pathological damages to lung tissues reduced. The number of inflammatory cells was decreased, and the levels of IL-6 and TNF-α levels declined (P0.05). Conclusion Mn supplementation protects against inflammatory responses in the lungs of obese asthmatic mice, and its mechanism is related to inhibited inflammatory responses.

关键词

肥胖 / 哮喘 / / 炎症反应

Key words

obesity / asthma / manganese / inflammatory response

引用本文

导出引用
黄莹, 张志彭, 高亮, 李红, 孟佳, 闫冬莹. 锰补充对肥胖哮喘小鼠肺部炎症反应的防治作用[J]. 营养学报. 2025, 47(4): 352-357
HUANG Ying, ZHANG Zhi-peng, GAO Liang, LI Hong, MENG Jia, YAN Dong-ying. EFFECTS OF MANGANESE SUPPLEMENTATION ON THE INFLAMMATORY RESPONSE IN THE LUNGS IN OBESE ASTHMATIC MICE[J]. Acta Nutrimenta Sinica. 2025, 47(4): 352-357
中图分类号: R114   

参考文献

[1] Agache I, Eguiluz-Gracia I, Cojanu C, et al. Advances and highlights in asthma in 2021[J]. Allergy, 2021, 76: 3390–3407.
[2] Rehman A, Amin F, Sadeeqa S.Prevalence of asthma and its management: a review[J]. J Pak Med Assoc, 2018, 68: 1823–1827.
[3] Jevnikar Z, Östling J, Ax E, et al. Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation[J]. J Allergy Clin Immunol, 2019, 143: 577–590.
[4] Dixon AE, Peters U.The effect of obesity on lung function[J]. Expert Rev Respir Med, 2018, 12: 755–767.
[5] Lv M, Chen M, Zhang R, et al. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy[J]. Cell Res, 2020, 30: 966–979.
[6] Zwingmann C, Leibfritz D, Hazell AS.Energy metabolism in astrocytes and neurons treated with manganese: relation among cell-specific energy failure, glucose metabolism, and intercellular trafficking using multinuclear NMR-spectroscopic analysis[J]. J Cereb Blood Flow Metab, 2003, 23: 756–771.
[7] Chen X, Yang G, Zhang B, et al. Effects of manganese-supplemented diets on growth performance, blood biochemistry, nitrogen metabolism and skeletal development of rex rabbits[J]. J Trace Elem Med Biol, 2020, 61: 126543.
[8] Koh ES, Kim SJ, Yoon HE, et al. Association of blood manganese level with diabetes and renal dysfunction: a cross-sectional study of the Korean general population[J]. BMC Endocr Disord, 2014, 14: 24.
[9] Li L, Yang X.The essential element manganese, oxidative stress, and metabolic diseases: links and interactions[J]. Oxid Med Cell Longev, 2018, 2018: 7580707.
[10] Niu F, Yu Y, Li Z, et al. Arginase: an emerging and promising therapeutic target for cancer treatment[J]. Biomed Pharmacother, 2022, 149: 112840.
[11] Fan XM, Luo Y, Cao YM, et al. Chronic manganese administration with longer intervals between injections produced neurotoxicity and hepatotoxicity in rats[J]. Neurochem Res, 2020, 45: 1941–1952.
[12] 张正则,刘浩,何悦雯,等.电针通过Keap1/Nrf2通路缓解哮喘小鼠肺组织铁死亡的机制研究[J/OL].针刺研究, 1-15[2025-06-24].
[13] Wang WJ, Lu X, Li Z, et al. Early-life cadmium exposure elevates susceptibility to allergic asthma in ovalbumin-sensitized and challenged mice[J]. Ecotoxicol Environ Saf, 2023, 255: 114799.
[14] Yıldız S, Gözü Pirinççioğlu A, Arıca E.Evaluation of heavy metal (lead, mercury, cadmium, and manganese) levels in blood, plasma, and urine of adolescents with aggressive behavior[J]. Cureus, 2023, 15: e33902.
[15] Porsbjerg C, Melén E, Lehtimäki L, et al. Asthma[J]. Lancet, 2023, 401: 858–873.
[16] Peters U, Dixon AE, Forno E.Obesity and asthma[J]. J Allergy Clin Immunol, 2018, 141: 1169–1179.
[17] 宋涛, 鲁继荣, 李善玉. 微量元素硒、锰、砷与小儿支气管哮喘的关系[J]. 中国妇幼保健, 2006(11): 1537–1539.
[18] Lo K, Yang JL, Chen CL, et al. Associations between blood and urinary manganese with metabolic syndrome and its components: cross-sectional analysis of national health and nutrition examination survey 2011-2016[J]. Sci Total Environ, 2021, 780: 146527.
[19] 叶桂林, 邱洪敏. 锰、氧化应激与代谢性疾病关系的研究进展[J]. 微量元素与健康研究, 2024, 4: 73–76.
[20] Ko SH, Park JH, Kim SY, et al. Antioxidant effects of spinach (Spinacia oleracea L.) supplementation in hyperlipidemic rats[J]. Prev Nutr Food Sci, 2014, 19: 19–26.

基金

辽宁省教育厅基本科研项目(No.jytqn2023437)

PDF(2286 KB)

Accesses

Citation

Detail

段落导航
相关文章

/